Critical and clinical test evaluations of mebendazole against internal parasites of the horse.
D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use; D002219:Carbamates / Q000627:therapeutic use*; D004175:Diptera; D004351:Drug Resistance; D005260:Female; D006734:Horse Diseases / Q000188:drug therapy*; D006736:Horses; D008297:Male; D009198:Myiasis / Q000188:drug therapy / Q000662:veterinary; D009349:Nematode Infections / Q000188:drug therapy / Q000662:veterinary; D010123:Oxyuriasis / Q000188:drug therapy / Q000662:veterinary; D010273:Parasitic Diseases, Animal; D013319:Strongyle Infections, Equine / Q000188:drug therapy; D013322:Strongyloidiasis / Q000188:drug therapy / Q000662:veterinary; D014201:Trematode Infections / Q000188:drug therapy / Q000662:veterinary; D014252:Trichostrongyloidiasis / Q000188:drug therapy / Q000662:veterinary
D000871:Anthelmintics; D001562:Benzimidazoles; D001565:Benzoates; D002219:Carbamates